TriangleHEALTH PROFESSIONAL · SOURCE READING
Peritoneal Carcinomatosis if Adenocarcinoma (Ovarian Paradigm)
Source: Cancer of Unknown Primary (CUP) Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 7, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Newly Diagnosed Favorable Cancer of Unknown Primary
Women with peritoneal carcinomatosis of an undifferentiated adenocarcinoma or serous histology in the absence of an ovarian, fallopian tube, or uterine primary site should undergo diagnostic testing and a therapeutic approach for ovarian cancer.[14] This is considered a primary peritoneal serous carcinoma.
Source links and citations
For more information, see Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment.
Source links and citations
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice